Candesartan Cilexetil/Rosuvastatin Calcium

坎地沙坦酯/瑞舒伐他汀钙

Report date: 2022/07/04 19:38:02

Base Information

Drug NameCandesartan Cilexetil/Rosuvastatin Calcium
Drug Alias Name瑞舒伐他汀钙/坎地沙坦酯Rosuvastatin Calcium/Candesartan CilexetilCandesartan cilexetil/rosuvastatinRosuvastatin/candesartanRosuvastatin Calcium and Candesartan Cilexetil +[6] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsHMG-CoA reductase inhibitors
TargetsAngiotensin II Receptor Type 1HMG-CoA reductase
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Candesartan CilexetilRosuvastatin Calcium
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlvogen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlvogen Korea
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A